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Glossary
•

Apoptosis: a controlled self-destruct mechanism within cells of the body that usually
follows cellular damage; colloquially known as programmed cell death.

•

Biofilm: blanket layer of one or more species of microorganisms, often adhered to a physical
surface such as the skin.

•

Fibroblast: creates an extracellular matrix to connect newly-formed epithelial cells in wound
healing.

•

Keratinocyte: layered within the epidermis and essential for innate immunity by providing
barrier to the external environment. After skin injury, keratinocytes migrate to the
wound and proliferate to repair the epithelial break. In chronic wounds, keratinocytes
are dysregulated (Pastar, 2014).

•

Microbiota: community of microorganisms of beneficial, neutral, or deleterious consequence
to a multicellular host.

•

Microorganisms of Interest:

•

Lactobacillus spp. (Lb. plantarum, Lb. rhamnosus, Lb. fermentum, etc.): genus of bacteria that
is naturally a part of the human microbiome, assisting in digestion and maintaining
microenvironments such as vaginal acidity. Lb. plantarum, Lb. rhamnosus, and Lb.
fermentum are examined as possible probiotics to facilitate the wound healing process.

•

Pseudomonadaceae: family of bacteria to which Pseudomonas aeruginosa belongs.

•

Pseudomonas aeruginosa: an opportunistic pathogen that can cause a multitude of dangerous
infections

•

Staphylococci spp. (S. epidermis, S. aureus, etc.): gram-positive cocci bacteria. Genus species
range in detriment to the human body in that S. epidermis and S. aureus can be
commensal, or beneficial, organisms typically found on the skin, whereas Methicillinresistant Staphylococcus aureus (MRSA) is often responsible for a variety of hard-to-treat
infections.

•

Streptococcus spp. (S. pyogenes, S. themophilus, etc.): gram-positive cocci bacteria. Genus
species are implicated in both human infections (S. pyogenes,) and as a possible topical
treatment (S. themophilus).
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Abstract
Chronic wound formation is an affliction that disproportionately affects those of lower
socioeconomic status on a global scale due to a variety of contributing factors, like type 2
diabetes and housing environment (Fayne, 2020). Antibiotic use in response to a cutaneous
wound selects for antibiotic-resistant bacteria, posing a risk for colonization by biofilmforming species that can result in chronic wounds. Biofilms decrease future antibiotic use
efficiency and inflames the surrounding tissue, potentially resulting in necrosis of the tissues.
Current studies show the possibility for probiotic application or reintroduction of commensal
organisms erased by antibiotic use as a therapeutic mechanism for cutaneous wounds. Here,
a two-step cutaneous wound treatment protocol is proposed involving antibiotic use and
subsequent bacteriotherapy as a preventative measure for chronic wound formation via
antibiotic-resistant bacteria.
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Introduction
Managing chronic wounds is a challenge around the world to individuals with
limited access to healthcare. A 2017 analysis of the economic burden placed upon patients
who were managing chronic wounds in the United States alone showed that approximately
5.7 million people accumulate an annual cost of at least $20 billion (Järbrink 2017). In
addition to the indefinite physical trauma of a chronic wound, economic and emotional
trauma is experienced not only by patients, but also by their families. Individuals of lower
socioeconomic status are more likely to experience medical conditions, such as type 2
diabetes or depression, that could exacerbate chronic wound development. Additionally,
a patient’s housing environment affects the healing rate of a chronic wound; for instance,
a lack of central heating can significantly stunt wound repair (Fayne 2020). As these
conditions disproportionately affect people in lower socioeconomic groups, who are often
underinsured, the development of cost-effective treatment of chronic wounds is vital to
the prevention of chronic wound-related emergencies, including amputation or even death
(Järbrink 2017). Understanding wound physiology and the skin microbiome is foundational
to curating bacterial-based therapeutics that could remedy chronic wounds.
Human bodies are covered with a vast and highly variable organ that is colloquially
referred to as “skin.” The expansive epithelial layer is embedded with different densities
of sweat glands, oil glands, hair, and other mucus producers. Skin contains a wide range
of viable ecosystems that can harbor different types of bacterial species. Sites with high
sebaceous gland content contained a larger bacterial load than other regions of the skin,
meaning that they contained a higher quantity of bacteria because of the moist, hospitable
environment (Johnson 2018). Conversely, drier sites of the body often express more microbial
diversity, or a wider variety of bacterial species (Grice 2009). Due to variations of both the
body and the skin’s environmental exposure, each human’s skin surface contains unique
microbial communities.
Depending on the host’s external environment and the region of the body that
is tested, up to two million bacteria can be isolated per square centimeter (Wong 2013).
Although the same general bacterial species can be found in its preferred skin ecosystem,
every volunteer in a 2009 study expressed different proportions of each species, suggesting
that each individual contains a skin microbiota composition unique to them (Grice
2009). Dissimilarities between skin microbiota makeups can be attributed to the inherent
differences of an individual host’s diet, immunological capabilities, and degree of sebaceous
secretion (Huffnagle 2013). Individual microbiota can be identified by a method known as
16S rRNA gene-based pyrosequencing, which identifies polymorphisms in the 16S gene
that is present in all bacteria. This method maximizes bacterial diversity recognition, since
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it identifies microorganism species missed through their lack of culture method compatibility
(Price 2009; Huffnagle 2013). Distinguishing the presence of these unnoticed bacterial species
on skin surfaces can contribute to understanding bacteria-wound interactions on the cutaneous
surface.
Wounds can be defined as physical breaks in epithelial integrity together with the
host’s subsequent response to repair this break (Huffnagle 2013). Alterations in the cutaneous
structure adjusts the physical and chemical parameters maintaining the composition of the
skin microbiome; as a result, wounds reduce the production of mucus, change the construction
of antimicrobial peptides, and also initiate an inflammatory response that ultimately causes
recovery at the wound site (Huffnagle 2013). A typical uninfected wound response includes
inflammation at the cutaneous break; this involves vasodilation and the recruitment of
cells to facilitate healing. Inflammation addresses the elimination of foreign and potentially
pathogenic microbes and their molecules via the migration of leukocytes, after which
reparation of the wound begins via proliferation of cell types like fibroblasts (Jones 200 ).
Although this mechanism is rapid for the sake of removing and excluding pathogenic bacteria
from the exposed tissue, these processes can actually be inhibited by the presence of such
pathogens. Subcutaneous tissue revealed via a wound in the cutaneous layer provides an
uncolonized oasis for opportunistic pathogens that can disrupt the wound-healing process and
stasis at the inflammatory stage; this is known as a chronic wound (Williams 2017).
The development of chronic wounds in patients is multifactorial and, ironically, can be
due to the medical efforts to prevent infection in the first place. Understanding the microbiome
of the skin can allow for specialized treatment that prevents chronic wound formation in
patients, especially vulnerable populations such as low-income or elderly individuals (Price
2009). The skin, much like the gut, experiences high levels of exposure to the surrounding
environment. Much of the research on the human microbiome has been centered on the
populations present in the digestive tract. Fewer efforts have been made toward defining the
cutaneous microbiome with 16S PCR only recently being used to better identify the microbes
that were missed while using culture methods. There is little understanding of the overarching
role of our skin microbiome, especially concerning wound healing promotion or inhibition
(Johnson 2018). Wound management often relates to the prevention of infection. While the
inherently negative impacts of our skin microbiome on wound repair have been assessed,
significantly less work has been done on how our microbiota and non-commensal organisms
could actually contribute to wound repair. Understanding wound microbiomes could allow us
to manipulate their population proportions in order to best treat subcutaneous wounds.
In a medical scenario where multiple skin abrasions are being treated, a topical or
oral antibiotic is often administered as a preventative measure against bacterial infection.
However, use of antibiotics can favor the infection of antibiotic-resistant bacteria, leading to a
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more severe and chronic infection of the cutaneous layer that could severely cost the patient
financially, emotionally, and physically. This serious side effect of antibiotic use could be
remedied using a topical application of various probiotics, such as Lactobacillus plantarum, that
can out-compete pathogenic bacteria to promote wound healing.

Pharmaceutical Disruption of the Skin Microbiome
Negatively Impacts Wound Closure
Typical Skin Microbiome Promotes Wound Healing
A 2011 study showed that keratinocytes in the skin are able to function normally in
the presence of commensal, or advantageous, organisms inhabiting the microbiome (Wanke
2011). In fact, it was found that the skin microbiome is capable of amplifying the immune
response against pathogenic bacteria. commensal organisms promote the low-level expression
of antimicrobial peptides, in order to prevent pathogenic bacterial growth on the skin. The
study also revealed that commensal and pathogenic Staphylococci spp. are important in the
development of antimicrobial peptides. Notably, the presence of pathogenic S. aureus on the
skin causes a high level of antimicrobial peptide expression that is toxic to pathogenic but not
commensal S. epidermidis, which have evolved protective mechanisms to those peptides. These
findings are reinforced by similar studies that have found that S. epidermis itself produces
molecules that promote antimicrobial peptide production by keratinocytes (Lai 2010; Wong
2013). Wanke et al. builds upon that research by showing that S. epidermis can simultaneously
promote the efficient removal of pathogens while protecting itself.

Treatment-Induced Infection
Patients with wounds in the cutaneous layer are routinely administered a preventative
dose of broad-spectrum antibiotics. If a chronic wound develops, antibiotic treatment is
continued. In a study to examine the effects of treatment on the microbial community,
researchers found that antibiotic use modifies bacterial communities instead of eliminating
them (Price 2009). This case study found an increased Pseudomonadaceae colonization
in wounds of patients that were recently treated with antibiotics, regardless of whether
these antibiotics were expected to be effective against Pseudomonas aeruginosa. P. aeruginosa
are known to grow planktonically, which means they do not have to bind themselves to a
biofilm in order to live. However, these P. aeruginosa were eliminated after being introduced
to antibiotics. Only biofilm-forming P. aeruginosa proved resistant to antibiotic treatment,
providing an advantage in infecting a dermal surface. After antibiotic treatment in the
hospital setting, bacterial diversity shifted dramatically to a Pseudomonas-dominated bacterial
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composition. This selection for biofilm-producing bacteria suggests that immediate antibiotic
use may contribute to formation of chronic wounds (Price 2009).
A recent study continued this work by testing the bacterial composition and wound
healing of mice treated with vancomycin; ultimately, they found that there was a changed
bacterial composition of the skin microbiota because of the antibiotic treatment (Zhang 2015).
Decreased bacterial density and an adjustment in bacterial diversity was observed with both
single-antibiotic treatment (vancomycin) and a combined antibiotic treatment (vancomycin,
clindamycin, polymyxin). Measurement of the wound area five days after the wound was
created showed that mice treated with antibiotics maintained a larger wound area than the
control mice, suggesting that there is a correlation between antibiotic use and delayed wound
healing (Zhang 2015).

Chronic Wound Development and Biofilm Formation
Antibiotic selection for biofilm-forming bacteria poses the possibility for the
development of chronic wounds. P. aeruginosa and Staphylococcus aureus (S. aureus) are often
responsible for the formation of such biofilms because of their resistance to antibiotics. When
antibiotics wipe out a wound’s microbial diversity and density, these pathogens then have
more space to colonize. The existence of a biofilm creates an impenetrable defense for the
infecting bacteria against immune cells, generating a state of chronic inflammation that in
turn further damages the wounded tissue (Price 2009; Watters 2015). One study found that
P. aeruginosa produces a lipid that traps bactericidal leukocytes and repurposes their lysed
components like DNA and actin to further reinforce the biofilm (van Gennip 2012). The
self-propagative nature of such infections contributes to the persistence of chronic wounds
and their inability to heal, as the host’s immune system cannot break down the biofilm of
infecting bacteria (Price 2009). The presence of biofilms also decreases the ability of antibiotics
to treat the infection, ultimately contributing to overuse of those antibiotics and subsequent
development of antibiotic-resistant microbes, such as methicillin-resistant Staphylococcus aureus
(MRSA) (Venosi 2019).
The pathogenesis of MRSA and its inhibition of human dermal fibroblasts from
reconstructing the epidermis after a cutaneous wound was recently examined (Kirker 2012).
This research revealed that dermal fibroblasts are responsible for excreting growth factors and
creating extracellular matrix molecules, and are vital for repairing a break in the skin, which
ultimately contributes to the natural reconstruction of the cutaneous layer (Kirker 2012). It was
found that the introduction of biofilm-forming species such as MRSA prevent dermal fibroblast
migration to the wound site and promote a programmed cell death of the fibroblasts called
apoptosis. The presence of MRSA within a biofilm downregulates the production of cytokines,
growth factors, and extracellular matrix-adjusting molecules such as protease, preventing
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wound healing at multiple stages (Kirker 2012). Using these findings as a foundation, a
2015 study increased the number of biofilm-forming species that were studied to include P.
aeruginosa (Marano 2015). More potent, denser biofilms that were typical of later-stage chronic
wounds (caused by both P. aeruginosa and MRSA) proved highly toxic to human keratinocytes,
which are involved in similar mechanisms to wound healing as dermal fibroblasts. As a result,
proliferation and migration of these tissue-regenerative cells were inhibited. Early biofilms
from both species affected the proliferative nature of keratinocytes through pathogen-secreted
anti-host cell compounds, but minimal effects were seen on migration (Marano 2015).

Restoration of the Skin Microbiome through Medical
Applications of Bacteria
Lactobacillus spp.
A variety of bacterial applications for repairing wounds are being explored as a means
of avoiding the aforementioned issues with antibiotic use and the development of chronic
wounds. A prominent study in this field discovered that topical administration of Lactobacillus
plantarum in vitro and in vivo fully prevented the infection of Pseudomonas aeruginosa, which is a
primary gram-negative perpetrator of biofilms that induces chronic wounds (Valdéz 2005). Lb.
plantarum prevents the production of P. aeruginosa via the production of secondary metabolites
that inhibit quorum-sensing molecules, which are important for later stage biofilm formation
(Valdéz 2005). While Lb. plantarum’s production of lactic acid via metabolism inhibited P.
aeruginosa growth, more inhibitory activity was seen as a result of Lb. plantarum’s occupation
of physical space with no significant detrimental effect to the host. Similarly, treatment of a P.
aeruginosa colonization induced tissue phagocytes to phagocytose, or to engulf, P. aeruginosa
and the Lb. plantarum used in the treatment. Consequentially, this decreased pathogenic
bacterial counts and promoted tissue repair (Valdéz 2005). Bacterial therapies decreased
premature tissue cell death (necrosis) and concentrations of inflammatory molecules in wound
sites. Although this research did not see a decrease in overall healing time of the wound, the
topical application of the bacterial therapy enabled the body to prevent biofilm formation at
wound sites (Valdéz 2005).
A 2014 study expanded upon this procedure, aiming to determine the effects of a
wider variety of Lactobacillus species on S. aureus biofilm formation. An analysis of the topical
application of live Lb. rhamnosus found that regardless of the time administered in relation to
the point of wound infliction, keratinocytes that were present at the wound site were protected
from S. aureus-induced apoptosis (Mohammedsaeed 2014). It was determined that the likely
cause of this protection is the prevention of S. aureus growth and adhesion, as seen by the

169

reduction in S. aureus bacterial count. A similar study confirmed Lb. plantarum’s ability to
physically prevent P. aeruginosa in burn wounds by displacing P. aeruginosa from the tissue and
physically occupying the space instead (Argenta 2016). This study also showed that topical
application of Lb. plantarum prevented pathogenic spread from the wound to distant organ
systems, thus preventing sepsis (Argenta 2016).
An earlier study showed that Lb. plantarum topical application shows greater efficacy
in the treatment of infected third-degree burns than the conventional microbicidal agent,
silver sulphadiazine, which can produce adverse reactions and side effects in cutaneous burn
wounds, calling for alternative treatments to be pursued (Peral 2009). These infections include
P. aeruginosa, similar to the Valdéz study, but also encompass S. aureus and Streptococcus
pyogenes. Overall, Lb. plantarum decreases the bacterial load and allows for the cutaneous
wound to repair itself (Lukic 2017). The mechanism behind this pathogenic bacteria removal
was proposed to include Lb. plantarum stimulation of immune system components previously
inhibited by P. aeruginosa (Hessle 2000). Although not explicitly stated in Peral et al.’s 2009
examination of Lb. plantarum inhibition of biofilm formation, the aforementioned cytokine
release and response could ultimately be responsible for the breakdown of the biofilm and thus
phagocytosis of pathogenic bacteria (Mohammedsaeed 2014).
The most recent notable application of these findings expanded upon the prior studies
by testing topical application and injection of probiotics on or near wound sites (Fijan 2019).
The study used a variety of cutaneous wound types, including both burn and cut wounds,
and found that probiotics maintain an antagonistic effect against wound pathogens, primarily
S. aureus and P. aeruginosa. The probiotics used included Lb. plantarum, Lb. fermentum, and
Cutibacterium acnes, all of which showed wound healing effects or inhibition of pathogenic
progress (Fijan 2019).

Staphylococcus Epidermis and Friends
Infection of cutaneous wounds by Staphylococcus aureus has also been shown as treatable
via the application of other bacterial species. Staphylococcus epidermis, a skin commensal
organism, was shown in Sugimoto et al. to produce Esp, a protease that prevents and
deconstructs biofilms created by S. aureus (Sugimoto 2013). This is also an effective method
against S. aureus strains that are methicillin- and vancomycin-resistant as Esp degrades a
variety of biofilm-associated surface proteins on S. aureus (Hessle 2000). By degrading the
biofilm extracellular matrix and destruction of proteins responsible for S. aureus attachment
and infection, host immune cells can attack pathogenic bacteria and prevent or eliminate
wound infection (Peral 2009). Similarly, another study showed that Staphylococcus spp. can
prevent prolonged, damaging inflammation in the cutaneous layer; S. epidermis secretes
triggers for keratinocytes to produce antimicrobial peptides (Wong 2013).

170

A recent study assessed a clinical case of a patient with an infected chronic ischemic
wound—a wound caused by stunted blood supply to the tissue—that sustained a
polymicrobial infection with pathogenic bacteria Klebsiella pneumoniae, Enterococcus faecalis
and Proteus mirabilis, which worsened after continued use of antibiotics (Venosi 2019).
The prolonged infection began to show signs of wound recovery after a topical probiotic
application of Lactobacillus plantarum, Lactobacillus acidophilus, and Streptococcus thermophilus.
Those metabolites which are often associated with promotion of bacterial infection were
altered, and this result could be associated with wound recovery. For example, polyamine
putrescine was reduced after the application of probiotic treatment. Polyamine putrescine is
involved with bacterial growth, biofilm formation, and protection from stress enacted by the
immune system (Venosi 2019).

Synthesis and Conclusions
Infection of cutaneous wound trauma is a common and justified fear within the
medical profession because of the possibility for sepsis or chronic wounds. However, in spite
of the negative association between bacteria and physical trauma, there are aspects of our
microbiome that contribute to the body’s ability to repair wounds. Disruption of microbiome
inhibits specific immune responses mediated by the microbiome. Similarly, broad-spectrum
antibiotics that are selected for antibiotic-resistant bacteria are commonly responsible for the
formation of biofilms. As shown by the aforementioned studies, commensal organisms can be
involved in inducing antimicrobial peptides that eliminate the presence of pathogenic bacteria,
but are also not toxic to the commensals due to evolved protection mechanisms (Lai 2010;
Wanke 2011). Given that commensal organisms then modulate the microbiome and prevent
regular infection of pathogenic bacteria, researchers should question the impact of immediate
use of broad-spectrum antibiotics on the skin microbiome.
Broad-spectrum antibiotic use can select for antibiotic-resistant species responsible for
biofilm production, such as P. aeruginosa and S. aureus, that ultimately colonize the wound and
can induce the formation of chronic wounds (Price 2009). The removal of competing organisms
allows the pathogenic bacteria to flourish and colonize the wound without restriction by
resource limitation. Although the rationale for preventative antibiotic use is evident, the broadspectrum nature of such use eliminates repair-promoting organisms that would not colonize
regions of the wound successfully. To further evidence this point: it was found that antibiotic
use could be associated with delayed wound healing; pure antibiotic use removes healing
organisms and instead opens the gates for opportunistic pathogens to infect, colonize, and
form biofilms over fresh cutaneous wounds (Zhang 2015). The infection enabled by antibiotic
use and consequent biofilm formation limits the ability of the wound to repair itself, and the
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presence of such biofilm-forming pathogens decrease migration of dermal fibroblasts to the
wound site (Kirker 2012). This also decreases the production of molecules and compounds
involved with dermal repair (van Gennip 2012; Marano 2015). This begs the question: to what
degree is the removal of commensal organisms in addition to pathogenic bacteria beneficial for
the repair of burn or cut wounds on the skin? Increased risk of chronic wound formation and
reduced wound healing due to the use of broad-spectrum antibiotic suggests that antibiotic
use needs to be supplemented with another therapeutic that inhibits biofilm growth.
The use of probiotics and reapplication of commensal bacteria lost through antibiotic
exposure has been shown to promote wound repair. Probiotic use (Lb. plantarum) was shown
to fully prevent infection of P. aeruginosa by inhibiting the species’ biofilm production,
leaving them exposed to immune cells (Valdéz 2005). In addition to acting as a preventative
bacteriotherapeutic, Lb. plantarum can be applied in late-stage biofilm formation through the

production of molecules that prevent bacterial communication in biofilms. That late-stage
application also prohibits the spread of harmful bacteria to adjacent sites and distant organs
(Peral 2009). Probiotics can be applied as an effective therapy against P. aeruginosa at any
stage in chronic wound formation, resulting in pathogenic cell death and lower concentrations
of inflammatory molecules (Valdéz 2005). Similar effects can be seen with Lb. rhamnosus in
their prevention of S. aureus-induced keratinocyte cell death while also reducing pathogenic
bacterial cell count (Mohammedsaeed 2014). More recent studies have shown that even more
bacterial species can be used to promote wound healing (for example, Lb. fermentum and
Propionibacterium acnes), which can open the possibility of more diversity in bacteriotherapy in
the coming years (Fijan 2019).
Lb. plantarum (and potentially other species) out-competes pathogenic bacteria and
creates a wound environment that is uninhabitable for organisms responsible for biofilm
formation. As such, Lb. plantarum can be used as a means for inhabiting a wound space as
a protection against harmful bacteria without inducing a chronic wound. The probiotics
can eliminate pathogenic bacteria responsible for maintaining a chronic wound before the
probiotics themselves are removed with treatments or the body’s natural immune response.
Probiotics can also be used as a shield against biofilm formation. Peral et al. also showed
that infected third-degree burns treated with Lb. plantarum show a greater healing rate than
classical treatments, posing the possibility that an additive step in conventional cutaneous
trauma treatment will ultimately promote healing and further prevent chronic wound
formation (Peral 2009). Potentially, a wide variety of Lactobacillus strains can be utilized for
therapeutic purposes, as the aforementioned strain also had a positive effect on wound healing
regardless of the stage of biofilm formation when it was applied.
In addition to probiotic application, there is a possibility for restoration of the patient’s
commensal organisms responsible for maintaining a biofilm-free wound site. S. epidermis was
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found to produce a protease that reduces and prevents biofilms caused by S. aureus (Sugimoto
2013). This aligns with prior findings that S. epidermis is responsible for a specialized immune
response, and that the elimination of the species from a wound site could delay wound
healing because of this alteration in strain-strain interaction. The reduction of S. epidermis load
at a wound site decreased the ability of the skin microbiota to prevent biofilm-forming and
antibiotic-resistant S. aureus from colonizing the site and inducing necrosis of the surrounding
tissues (Hessle 2000; Zhang, 2015).
While there are numerous benefits to utilizing probiotics in wound care and
management, there are notable risks, as well. A common understanding of bacteria includes
the broad generalization that all bacterial species, except those supporting our digestion, pose
a risk to human health. Many studies point out the human concern that topical application
of any probiotic to a cutaneous wound increases risk of septicemia, or bacterial infection
of the blood (Mohammedsaeed 2014; Watters 2015). And, indeed, there is a possibility that
Lactobacillus septicemia is more likely in immunocompromised individuals; a retroactive study
conducted found that Lb. rhamnosus bacteremia was found in 66% of immunosuppressed
patients, and 82.5% of catheterized patients, which increases the risk for consequential
septicemia (Gouriet 2012). If practitioners increase probiotic use in these cases, there is also a
parallel increased risk for cases of septicemia.
Although there is a reasonable concern for septicemia in individuals particularly
vulnerable to infection, it can be considered that the risk of septicemia is lower than the risk
posed by chronic wounds, where the degree of inflammation is so damaging that it prevents
any ability to fight infection by physically retaining immune cells and also by promoting
further tissue destruction (Valdéz 2005). A topical application of Lb. plantarum can then inhibit
the exacerbated immune system to biofilm-forming bacteria in chronic wounds. Current
wound management techniques are based on reducing bacterial load and preventing infection,
but harsh antimicrobial protocols can negatively impact the bacterial species composition of
the wound environment to ironically favor infection (Price 2009). Adjusting our approach
to wound healing in order to permit a two-step method of antibiotic and subsequent
probiotic application (as shown in Figure 1) can prevent the formation of chronic wounds.
Three stages of wound healing are indicated. Figure 1A shows a fresh cutaneous wound has
antibiotics topically applied, and Figure 1B shows a subsequent response where antibioticresistant bacteria begin early stages of biofilm formation. It is at this point that a probiotic
bacteriotherapy is applied, the effect of which is shown in Figure 1C, where the biofilm is
deconstructed by the probiotic and regenerative cells are able to begin re-epithelialization.

173

Figure 1 Proposed standard protocol for cutaneous wound
management in the prevention of chronic wound formation.

Manipulation of the wound ecosystem with probiotics acts as a cost-effective alternative
treatment that subverts the cost of continued antibiotic use and the healthcare that comes with
chronic wound management (Johnson 2018). This would reduce the annual billions of dollars
spent on chronic wounds as well as decelerate the development of antibiotic-resistance due
to futile attempts at diminishing chronic wounds via chronic antibiotic administration. Easily
culturable bacteria as a therapy can promote infection management for patients with income
limitations, paving the way for access to more diverse healthcare methods.
As has been stated, chronic wounds disproportionately affect people in lower
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socioeconomic conditions. For example, individuals in lower socioeconomic groups are more
likely to develop a chronic wound, and individuals who are unemployed were found to be 2.44
times more likely to develop a chronic wound than their employed counterparts (Yao 2020).
Taking together the duration of chronic wounds, the increased chronic wound development
rate, and the decreased recovery rate from chronic wounds experienced by lower- or noincome individuals, a statistic emerges that unemployed patients are 12.34 times more likely
to be afflicted with a chronic wound than unemployed individuals (Yao 2020). Low-income
individuals are also more likely to have decreased or stunted healing due to conditions that are
directly related to their income and resources and thus out of their control. The increased stress
of economic burden leads to an increase in stress hormones, impairing wound repair (Fayne
2020). Nutritional deficiencies, housing security and quality, marital status, and a wide range
of impacts from economic hardship also extend the lifespan of a chronic wound (Fayne 2020).
In summary, those in lower socioeconomic groups carry the burden of chronic wounds more
than people with access to economic success.
Chronic wounds make up a large percentage of annual healthcare expenses around
the world. In addition to the above 2017 US analysis stating that an annual cost of $20 billion
in healthcare expenses is accrued nationally because of chronic wounds, a study of Northern
China from the same year showed that annual hospital costs for a single patient treating
chronic wounds amounted to around US $1,271,000 (Yao 2020). Chronic wound patients
in Northern China contribute to 3.18% of all of healthcare expenses in 2017 (Yao 2020). On
a global scale, lower-income individuals disproportionately carry the burden of chronic
wound affliction, and as a result, they also make up the bulk of these medical expenditures.
In the study that evaluated Northern China’s chronic wound healthcare expenses, it was
found that more than 10% of chronic wound patients, including those experiencing diabetes,
infection, pressure ulcers, or even surgery, had to pay for their own medical bills (Yao 2020).
The development of more cost-effective and accessible treatments will relieve the burden of
these medical expenses, allowing those who are affected at a higher rate to receive the care
they need without fear of further economic burden. By standardizing a method of care that
will decrease further psychosocial strain, which would further impact wound repair, the cost
of wound management could be reduced up to 30% (Järbrink 2017). Probiotic bacteriotherapy
holds promise in providing reduced-cost treatment. Accepting the use of beneficial bacteria
in the treatment of chronic wound patients may not only relieve the physical, psychological,
and familial detriments caused by chronic wounds, but could also mark a broader transition to
treatments that go beyond expense.
Preventative measures against chronic wound formation would ensure that the wound
environment remains inhospitable to the pathogens remaining after antibiotic exposure,
reducing not just inflammation but the negative psychological and physical effects associated
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with a chronic wound. Adjusting our approach to wound healing will eventually benefit
patients, utilizing an existing organism to decrease wound pH, reduce inflammation at
the wound site, and inhibit further infection by pathogenic bacteria (Johnson 2018). While
further research should investigate the susceptibility of immunocompromised individuals
to septicemia due to topical application of live probiotics as opposed to their antimicrobial
byproducts, the current data proposes positive effects of bacterial application as a disruptive
and preventative ward against chronic wounds. Ultimately, disrupting our current paradigm
regarding bacteria can pave the way for a new wave of bacteriotherapy in healthcare.
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